Effect of Xinmailong Injection on heart function and levels of inflammatory factors and miR⁃23a in elderly patients with heart failure after acute myocardial infarction
Clinical Research|更新时间:2022-08-29
|
Effect of Xinmailong Injection on heart function and levels of inflammatory factors and miR⁃23a in elderly patients with heart failure after acute myocardial infarction
Academic Journal of Shanghai University of Traditional Chinese MedicineVol. 36, Issue 2, Pages: 20-25(2022)
SONG Fangfang,ZHANG Qianqian,LI Chunyan.Effect of Xinmailong Injection on heart function and levels of inflammatory factors and miR⁃23a in elderly patients with heart failure after acute myocardial infarction[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(02):20-25.
SONG Fangfang,ZHANG Qianqian,LI Chunyan.Effect of Xinmailong Injection on heart function and levels of inflammatory factors and miR⁃23a in elderly patients with heart failure after acute myocardial infarction[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(02):20-25. DOI: 10.16306/j.1008-861x.2022.02.004.
Effect of Xinmailong Injection on heart function and levels of inflammatory factors and miR⁃23a in elderly patients with heart failure after acute myocardial infarction
Objective: To explore the effect of Xinmailong Injection on the heart function and the levels of inflammatory factors and miR-23a in elderly patients with heart failure after acute myocardial infarction (AMI).,Methods,2,A total of 120 elderly patients with heart failure after AMI were included and randomly divided into the treatment group and control group, 60 cases in each group. The patients in both groups were treated with routine treatment, and the patients in the treatment group were treated with intravenous drip of Xinmailong Injection on the basis of routine treatment, with a course of 7 days. Before and after treatment, the levels of cardiac function indexes including left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), stroke volume (SV) and left ventricular ejection fraction (LVEF), inflammatory factors including interleukin (IL)-6, tumor necrosis factor-α (TNF-α) and high sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP) and peripheral blood miR-23a level were detected. The ,Pearson, correlation analysis was used to evaluate the correlation between the miR-23a level and the cardiac function indexes, inflammatory factors and NT-proBNP levels of the patients.,Results,2,①After treatment, the levels of LVEF and SV in the two groups were increased compared with those before treatment (,P,<,0.05), the levels of LVEDD and LVESD were decreased compared with those before treatment (,P,<,0.05), and the levels of LVEF and SV in the treatment group were higher than those in the control group (,P,<,0.05), the levels of LVEDD and LVESD were lower than those in the control group (,P,<,0.05). ②After treatment, the levels of IL-6, TNF-α, hs-CRP and NT-proBNP in the two groups were significantly decreased compared with those before treatment (,P,<,0.05), and the levels of IL-6, TNF-α, hs-CRP and NT-proBNP in the treatment group were lower than those in the control group (,P,<,0.05). ③After treatment, the levels of peripheral blood miR-23a in both groups were increased compared with those before treatment (,P,<,0.05), and the level of peripheral blood miR-23a in the treatment group was higher than that in the control group (,P,<,0.05). ④Before treatment, the miR-23a level of the patients was negatively correlated with the levels of IL-6, TNF-α, hs-CRP and NT-proBNP.,Conclusion,2,Compared with conventional therapy, Xinmailong Injection combined with conventional therapy can better improve the cardiac function and inflammatory status, and increase the expression level of peripheral blood miR-23a in treating elderly patients with heart failure after AMI, which has certain clinical treatment value.
PALAZZUOLI A, PELLEGRINI M, FRANCI B, et al. Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction[J]. Intern Emerg Med, 2015, 10(1): 41-49.
QI J Y, YU J, TAN Y F, et al. Mechanisms of Chinese Medicine Xinmailong’s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes[J]. Sci Rep, 2017, 7: 42843.
BARWARI T, JOSHI A, MAYR M. MicroRNAs in Cardiovascular Disease[J]. J Am Coll Cardiol, 2016, 68(23): 2577-2584.
JOSHI N V, TOOR I, SHAH A S, et al. Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction[J]. J Am Heart Assoc, 2015, 4(9): e001956.
SONG R, HU X Q, ZHANG L B. Mitochondrial MiRNA in Cardiovascular Function and Disease[J]. Cells, 2019, 8(12): 1475.
WANG Q, LIU B Y, WANG Y Y, et al. The biomarkers of key miRNAs and target genes associated with acute myocardial infarction[J]. PeerJ, 2020, 8: e9129.
BUKAUSKAS T, MICKUS R, CERESKEVICIUS D, et al. Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction[J]. Med Sci Monit, 2019, 25: 3925-3932.
PONIKOWSKI P, VOORS A A, ANKER S D, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur J Heart Fail, 2016, 18(8): 891-975.
MAHTTA D, SUDHAKAR D, KONERU S, et al. Targeting Inflammation After Myocardial Infarction[J]. Curr Cardiol Rep, 2020, 22(10): 110.
LI S S, PAN G J, CHEN H L, et al. Determination of Serum Homocysteine and Hypersensitive C-reactive Protein and Their Correlation with Premature Coronary Heart Disease[J]. Heart Surg Forum, 2019, 22(3): E215-E217.
SANTAGUIDA P L, DON-WAUCHOPE A C, OREMUS M, et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review[J]. Heart Fail Rev, 2014, 19(4): 453-470.
STIENEN S, SALAH K, MOONS A H, et al. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA Ⅱ Randomized Controlled Trial[J]. Circulation, 2018, 137(16): 1671-1683.
VALERO CIFUENTES S, GARCIA VILLALBA E, ALCARAZ GARCIA A, et al. Prognostic value of pro-adrenomedullin and NT-proBNP in patients referred from the emergency department with influenza syndrome[J]. Emergencias, 2019, 31(3): 180-184.
CEN W, CHEN Z L, GU N, et al. Prevention of AMI Induced Ventricular Remodeling: Inhibitory Effects of Heart-Protecting Musk Pill on IL-6 and TNF-α[J]. Evid Based Complement Alternat Med, 2017, 2017: 3217395.
WOJCIECHOWSKA A, BRANIEWSKA A, KOZAR-KAMINSKA K. MicroRNA in cardiovascular biology and disease[J]. Adv Clin Exp Med, 2017, 26(5): 865-874.
LI S L, REN J, SUN Q M. The expression of microRNA-23a regulates acute myocardial infarction in patients and in vitro through targeting PTEN[J]. Mol Med Rep, 2018, 17(5): 6866-6872.
HAN H, QU G J, HAN C H, et al. MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32-patient cohort[J]. Exp Mol Med, 2015, 47(2): e138.
HERMENEGILDO C, MOMPEON A, JANUARIO T, et al. Comparative analysis of miRNA expression in serum and plasma of patient[J]. J Hypertens, 2017, 35: e204.
PENG P, LI Z Y, LIU X Y. Reduced Expression of miR-23a Suppresses A20 in TLR-stimulated Macrophages[J]. Inflammation, 2015, 38(5): 1787-1793.
Clinical efficacy of Yanghe Decoction in patients with breast cancer receiving neo⁃adjuvant chemotherapy and its impact on inflammatory factors
Clinical observation of Lujiao Zhuangdu Decoction in treating ankylosing spondylitis
Clinical observation of Shenshuaiyi Formula in treatment of chronic kidney disease at stage 4 combined with chronic heart failure
Exploration on mechanism of Wuling Powder combined with Taohong Siwu Decoction in treatment of heart failure based on network pharmacology, molecular docking, and experimental validation
Effect of Compound Danshen Dripping Pill on MACE and ventricular remodeling improvement in patients with acute myocardial infarction after PCI: a Meta⁃analysis
Related Author
No data
Related Institution
Department of Breast Disease, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Rheumatology Department, Shanghai Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Yidan Nursing Home
Inheritance Studio of Ye Jinghua National Famous Doctor of Traditional Chinese Medicine
Department of Nephrology, the Seventh People’s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine